China Medical System Holdings Limited(AIM:CMSH) is pleased to announce that Summit Forum of Fatty Liver Disease(FLD) was hold in Shanghai Everbright Convention & Exhibition Center on 17th May by Chinese Society of Hepatology(CMA)， Shanghai Research Center of Fatty Liver Disease， Shanghai Society of Hepatology and Chinese Hepatology(Magazine)， in which CMS participated as a co-organizer.
Thirteen nationwide opinion leaders in the fields of hepatology， endocrinology and cardiovasology gave special reports on research progress and hot issues of FLD， which will form the continuing education materials named the Latest Development of Diagnosis and Treatment in FLD. More than 90 experts attended the forum and held a heated discussion after which they expressed that the prevention and treatment of FLD was not only an issue of clinical medicine， but also a major topic for preventive medicine， social medicine and administrative departments of sanitation. It needs the collaboration among experts from different fields. We believe that this forum will promote the progress in diagnosis and treatment of FLD in China， and as a quality imported drug for liver disease， Ursofalk is strongly believed to have further potential and benefit more sufferers.